Flow diagram. by Cristina Dolciotti (16317330)

Subjects:

PLB is a target gene of miRNA 221. by Hongyu Li (1332669)

Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. by Nattapon Riengvirodkij (11268720)

Subjects:

EDLIoT: A method for decreasing energy consumption and latency using scheduling algorithm in Internet of Things by Arash GhorbanniaDelavar (22563696)

Graphical presentation of % decrease for C-peptide from baseline at different conditions. by Nathan Mubiru (21627195)

Infection of humanized mice resulted in decrease in pathogenicity in HTLV-1-CTCF infected mice. by Ancy Joseph (5634794)

Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in oxidative stress levels. by Qi He (384033)

Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in lipid peroxidation levels. by Qi He (384033)

A sample choice question with a warning label. by Yulian Ding (5984591)

“…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”

HFD decreases ITM and alters metabolic homeostasis. by Tong Yue (6033305)

“…Two-way ANOVA, n.s., not significant, ** p < 0.01). <b>(F)</b> Long-term memory (LTM) was significantly decreased in the HFD group. …”

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”

S1 Data - by Du Siqi (20721422)

Subjects:

S1 File - by Du Siqi (20721422)

Subjects:

Genera associated with FC, symptom score or week to treatment. by Katrine Carlsen (5477300)

Subjects:

Patient demographics. by Katrine Carlsen (5477300)

Subjects:

Alpha diversity measures across all 727 samples. by Katrine Carlsen (5477300)

Subjects:

STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

Subjects:

S5 Fig - by Katrine Carlsen (5477300)

Subjects:

Association across weeks to treatment for three genera. by Katrine Carlsen (5477300)

Subjects:

Microbiome profile of the most abundant phyla in one patient (Patient 1), across 12 infliximab treatments (-1 is the week before treatment, -2 the two weeks before treatment, etc). by Katrine Carlsen (5477300)

Subjects: